Relevant bibliographies by topics / Neuromuscular blocker

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Neuromuscular blocker'

Author: Grafiati
Published: 5 June 2025
Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Neuromuscular blocker.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Neuromuscular blocker"

1

&NA;. "Neuromuscular blocker interactions." Reactions Weekly &NA;, no. 315 (1990): 7. http://dx.doi.org/10.2165/00128415-199003150-00026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Braga, Angélica de Fátima de Assunção, Derli Conceição Munoz, Franklin Sarmento da Silva Braga, Daniele Ribeiro de Araujo, Glória Maria Braga Potério, and Mario Mantovani. "Influence of stimulus frequency on blockade induced by pancuronium and rocuronium: study on rats phrenic nerve-diaphragm preparation." Acta Cirurgica Brasileira 22, no. 6 (2007): 446–50. http://dx.doi.org/10.1590/s0102-86502007000600006.

Full text
Abstract:
PURPOSE: To evaluate the influence of two stimulation frequencies on the installation of neuromuscular blockade produced by pancuronium and rocuronium on the rat diaphragm. METHODS: Diaphragms were submitted to an indirect frequency stimulation of 0.1 and 1Hz (Groups I and II, respectively). Subgroups were formed (n=5) according to the neuromuscular blocker employed (pancuronium-2µg/ml and rocuronium-4µg/ml). The twitch height depression was evaluated at 5, 15 and 30 minutes after adding the neuromuscular blocker. RESULTS: The decrease in twitch height was greater (p<0.01) with a frequency
APA, Harvard, Vancouver, ISO, and other styles
3

&NA;. "Enflurane see Neuromuscular blocker interactions." Reactions Weekly &NA;, no. 315 (1990): 5. http://dx.doi.org/10.2165/00128415-199003150-00018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Halothane see Neuromuscular blocker interactions." Reactions Weekly &NA;, no. 315 (1990): 5. http://dx.doi.org/10.2165/00128415-199003150-00020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Savings with neuromuscular blocker guidelines." Inpharma Weekly &NA;, no. 1006 (1995): 7. http://dx.doi.org/10.2165/00128413-199510060-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Grillot, Nicolas, Gilles Lebuffe, Olivier Huet, et al. "Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration." JAMA 329, no. 1 (2023): 28. http://dx.doi.org/10.1001/jama.2022.23550.

Full text
Abstract:
ImportanceIt is uncertain whether a rapid-onset opioid is noninferior to a rapid-onset neuromuscular blocker during rapid sequence intubation when used in conjunction with a hypnotic agent.ObjectiveTo determine whether remifentanil is noninferior to rapid-onset neuromuscular blockers for rapid sequence intubation.Design, Setting, and ParticipantsMulticenter, randomized, open-label, noninferiority trial among 1150 adults at risk of aspiration (fasting for <6 hours, bowel occlusion, recent trauma, or severe gastroesophageal reflux) who underwent tracheal intubation in the operating ro
APA, Harvard, Vancouver, ISO, and other styles
7

Miller, Jane L. "New short-acting neuromuscular blocker released." American Journal of Health-System Pharmacy 56, no. 21 (1999): 2178. http://dx.doi.org/10.1093/ajhp/56.21.2178a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

&NA;. "New improved neuromuscular blocker for the US." Inpharma Weekly &NA;, no. 1019 (1996): 22. http://dx.doi.org/10.2165/00128413-199610190-00046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

&NA;. "Vecuronium bromide preferred neuromuscular blocker in ICU." Inpharma Weekly &NA;, no. 861 (1992): 15. http://dx.doi.org/10.2165/00128413-199208610-00034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pino, Richard M. "Neuromuscular blocker studies of critically ill patients." Intensive Care Medicine 28, no. 12 (2002): 1695–97. http://dx.doi.org/10.1007/s00134-002-1510-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Neuromuscular blocker"

1

Elofson, Kathryn, and Sarah Girardot. "Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients." The University of Arizona, 2012. http://hdl.handle.net/10150/623607.

Full text
Abstract:
Class of 2012 Abstract<br>Specific Aims: During pre-hospital transport, trauma patients may be given a long-acting neuromuscular blocker (NMB) to facilitate endotracheal intubation or to prevent movement. The purpose of this study was to determine the rate of long-acting NMB use and evaluate the concurrent use of sedatives. Methods: This was a retrospective cohort study conducted in a tertiary care, academic emergency department of trauma patients aged 18-89 years who were intubated in the pre-hospital setting. The primary outcome was to determine the rate of long-acting NMB use. The use of p
APA, Harvard, Vancouver, ISO, and other styles
2

Elofson, Kathryn, Sarah Girardot, and Asad Patanwala. "Long-Acting Neuromuscular Blocker use During Pre-Hospital Transport of Critically Ill Trauma Patients." The University of Arizona, 2012. http://hdl.handle.net/10150/614468.

Full text
Abstract:
Class of 2012 Abstract<br>Specific Aims: During pre-hospital transport, trauma patients may be given a long-acting neuromuscular blocker (NMB) to facilitate endotracheal intubation or to prevent movement. The purpose of this study was to determine the rate of long-acting NMB use and evaluate the concurrent use of sedatives. Methods: This was a retrospective cohort study conducted in a tertiary care, academic emergency department of trauma patients aged 18-89 years who were intubated in the pre-hospital setting. The primary outcome was to determine the rate of long-acting NMB use. The use o
APA, Harvard, Vancouver, ISO, and other styles
3

Carvalho, Vanessa Henriques 1974. "Efeitos dos anestesicos locais na transmissão neuromuscular e no bloqueio produzido pelo rocuronio : estudo experimental." [s.n.], 2009. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308162.

Full text
Abstract:
Orientadores: Angelica de Fatima de Assunção Braga, Franklin Sarmento da Silva Braga<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas<br>Made available in DSpace on 2018-08-12T22:04:04Z (GMT). No. of bitstreams: 1 Carvalho_VanessaHenriques_M.pdf: 2016873 bytes, checksum: ed79870ad9763d6497595ceb7fdcf4ba (MD5) Previous issue date: 2009<br>Resumo: Os anestésicos locais podem interagir com os bloqueadores neuromusculares e modificar as suas propriedades farmacocinéticas e farmacodinâmicas, no entanto o mecanismo dessa interação é controverso. Este est
APA, Harvard, Vancouver, ISO, and other styles
4

Hurford, William E. "Sugammadex vs. neostigmine/glycopyrrolate for routine reversal of rocuronium block in adult patients." University of Cincinnati / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1573224876100739.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Moro, Eduardo Toshiyuki [UNESP]. "Efeito do propofol associado à efedrina no tempo da latência do cisatracúrio." Universidade Estadual Paulista (UNESP), 2006. http://hdl.handle.net/11449/97724.

Full text
Abstract:
Made available in DSpace on 2014-06-11T19:29:05Z (GMT). No. of bitstreams: 0 Previous issue date: 2006-11-24Bitstream added on 2014-06-13T19:37:58Z : No. of bitstreams: 1 moro_et_me_botfm.pdf: 465770 bytes, checksum: 4a10047a2171b9c6542fe3eba27f15c5 (MD5)<br>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)<br>Universidade Estadual Paulista (UNESP)<br>Justificativa e Objetivos: o início de ação dos agentes bloqueadores neuromusculares pode ser influenciado por fatores que incluem a distância do músculo ao coração, o fluxo sangüíneo muscular e o débito cardíaco. O propofol p
APA, Harvard, Vancouver, ISO, and other styles
6

Moro, Eduardo Toshiyuki. "Efeito do propofol associado à efedrina no tempo da latência do cisatracúrio /." Botucatu : [s.n.], 2006. http://hdl.handle.net/11449/97724.

Full text
Abstract:
Orientador: Norma Sueli Pinheiro Módolo<br>Banca: Eliana M. Ganem<br>Banca: Angélica de Fátima Assunção Braga<br>Resumo: Justificativa e Objetivos: o início de ação dos agentes bloqueadores neuromusculares pode ser influenciado por fatores que incluem a distância do músculo ao coração, o fluxo sangüíneo muscular e o débito cardíaco. O propofol pode causar hipotensão arterial, principalmente quando associado a um opióide, o que diminuiria o fluxo sangüíneo muscular e, portanto tem sido citado como um fator responsável pelo aumento do tempo de latência dos bloqueadores neuromusculares. O objetiv
APA, Harvard, Vancouver, ISO, and other styles
7

Gustafsson, Anna, and Agneta Sjöholm-Olsson. "Anestesisjuksköterskans strategier vid användandet av muskelrelaxantia." Thesis, Högskolan i Halmstad, Sektionen för hälsa och samhälle (HOS), 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-24383.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

DUARTE, Nádia Maria da Conceição. "Sugamadex em peso ideal versus peso corrigido em 20% e 40% para reversão de bloqueio neuromuscular em cirurgia bariátrica — ensaio clínico randomizado duplamente encoberto." Universidade Federal de Pernambuco, 2016. https://repositorio.ufpe.br/handle/123456789/20157.

Full text
Abstract:
Submitted by Fabio Sobreira Campos da Costa (fabio.sobreira@ufpe.br) on 2017-07-31T12:22:14Z No. of bitstreams: 2 license_rdf: 811 bytes, checksum: e39d27027a6cc9cb039ad269a5db8e34 (MD5) Dissertação Mestrado Nádia M C Duarte UFPE Biblioteca Arquivo digital 01 março 2016 .pdf: 568588 bytes, checksum: 57ce6c1480b95a9035dd70862d2b1d7b (MD5)<br>Made available in DSpace on 2017-07-31T12:22:14Z (GMT). No. of bitstreams: 2 license_rdf: 811 bytes, checksum: e39d27027a6cc9cb039ad269a5db8e34 (MD5) Dissertação Mestrado Nádia M C Duarte UFPE Biblioteca Arquivo digital 01 março 2016 .pdf: 568588 bytes, che
APA, Harvard, Vancouver, ISO, and other styles
9

Van, den Berg Maurits Matthew. "Magnesium recurarisation differences between no reversal, neostigmine/glycopyrrolate reversal and sugammadex reversal of neuromuscular block in an in vivo rat model." Master's thesis, University of Cape Town, 2016. http://hdl.handle.net/11427/20493.

Full text
Abstract:
The neuromuscular junction (NMJ) is a synapse with one of the highest safety margins in the human body. The use of neuromuscular blocking agents to inhibit neuromuscular transmission is sufficient to produce skeletal muscle paralysis, a mechanism used to facilitate muscle relaxation during surgery. Residual neuromuscular block postoperatively has been found to be a major risk factor for postoperative complications. Sudden reinstatement of neuromuscular block (recurarisation), through use of magnesium, has also been observed clinically. This has led to a reluctance to use magnesium postoperativ
APA, Harvard, Vancouver, ISO, and other styles
10

Schaller, Stefan [Verfasser], Heidrun [Akademischer Betreuer] Fink, and Peter [Akademischer Betreuer] Tassani-Prell. "Sugammadex and Neostigmine Dose-finding Study for Reversal of Residual Neuromuscular Block (Sundro-Study) / Stefan Schaller. Gutachter: Peter Tassani-Prell ; Heidrun Fink. Betreuer: Heidrun Fink." München : Universitätsbibliothek der TU München, 2013. http://d-nb.info/1046404849/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Neuromuscular blocker"

1

G, Silverman David, ed. Neuromuscular block: In perioperative and intensive care. Lippincott, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kotsios, Mae Melpomeni. Muscle metabolism during simulated forced dives in Pekin ducks (anas platyrhynchos) and neuromuscular blockers as a tool to test for the existence of a central motor. National Library of Canada, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wijdicks, Eelco F. M., and Sarah L. Clark. Analgosedation and Neuromuscular Blockers. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190684747.003.0002.

Full text
Abstract:
Sedation is beneficial to many restless patients but it may prolong the length of stay in the intensive care unit, prolong time on the ventilator, and have negative effects on the cardiovascular system, causing hemodynamic instability. Use of neuromuscular blockers has decreased due to better awareness of the risks. These risks include prolonged intensive-care-unit–acquired weakness, prolonged mechanical ventilation, risk of patient awareness during paralysis, risk for venous thromboembolism, and anaphylaxis. It is therefore important to have a good knowledge of these drugs and when to use the
APA, Harvard, Vancouver, ISO, and other styles
4

Neuromuscular block. Butterworth-Heinemann, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lambert, David G. Mechanisms and determinants of anaesthetic drug action. Edited by Michel M. R. F. Struys. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0013.

Full text
Abstract:
This chapter is broken into two main sections: a general description of the principles of ligand receptor interaction and a discussion of the main groups of ‘targets’; and explanation of some common pharmacological interactions in anaesthesia, critical care, and pain management. Agonists bind to and activate receptors while antagonists bind to receptors and block the effects of agonists. Antagonists can be competitive (most common) or non-competitive/irreversible. The main classes of drug target are enzymes, carriers, ion channels, and receptors with examples of anaesthetic relevance interacti
APA, Harvard, Vancouver, ISO, and other styles
6

Hunter, Jennifer M., and Thomas Fuchs-Buder. Neuromuscular blockade and reversal. Edited by Michel M. R. F. Struys. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0016.

Full text
Abstract:
Over the past 70 years since the introduction of d-tubocurarine, the search for an ideal neuromuscular blocking agent has led to the development of the depolarizing drug, succinylcholine (suxamethonium), with its rapid onset of action and plasma metabolism, and a series of non-depolarizing agents of which there are two groups: benzylisoquinoliniums (e.g. atracurium, cisatracurium and mivacurium) and aminosteroidal agents (e.g. pancuronium, vecuronium and rocuronium). The need to monitor neuromuscular block perioperatively to ensure the appropriate dose of any neuromuscular blocking drug is giv
APA, Harvard, Vancouver, ISO, and other styles
7

Silverman, David G. Neuromuscular Block: In Perioperative and Intensive Care. Lippincott Williams & Wilkins, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pollard, Brian J. Muscle relaxants in critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0047.

Full text
Abstract:
The place of neuromuscular blocking agents in the intensive care unit (ICU) has changed markedly over the last 20 years. Originally regarded as a mainstay of the process of ‘sedation’, they are now only used for specific indications. The principal disadvantage is probably the difficulty in neurological assessment when a muscle relaxant is used coupled with the increased risk of awareness, because inadequate sedation will be masked. Of the available agents, the intermediate acting ones are the most popular. The degree of relaxation can be readily controlled and they have few side effects. In th
APA, Harvard, Vancouver, ISO, and other styles
9

McKenzie, Alistair G. The history of anaesthesia. Edited by Philip M. Hopkins. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0031.

Full text
Abstract:
Even though ether was prepared in 1540 and nitrous oxide in 1774, it was not until the 1840s that these agents were used to induce anaesthesia to enable painless surgery. Modern inhalation anaesthesia has evolved from the public demonstration of ether anaesthesia by William Morton at the Massachusetts General Hospital, Boston, United States, on 16 October 1846. In the United Kingdom, from 1847 John Snow applied scientific principles to develop safer anaesthetic practice. Newer and safer agents have replaced ether in most countries. Successful intravenous anaesthesia began with chloral hydrate
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Neuromuscular blocker"

1

Langham, Geoffrey. "A Defasciculating Dose of Nondepolarizing Neuromuscular Blocker." In Clinical Anesthesiology. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8696-1_53.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Goodwin, Gabriel, and Vilma Joseph. "Neuromuscular Blockers." In Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-8948-1_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ruff, Paul G. "Neuromuscular Blockers." In Cosmesis of the Mouth, Face and Jaws. John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118704677.ch9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Murrell, Matthew T., and John J. Savarese. "New Vistas in Neuromuscular Blockers." In Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-8948-1_52.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jack, David B. "Pharmacokinetic data on anaesthetics and neuromuscular blockers." In Handbook of Clinical Pharmacokinetic Data. Palgrave Macmillan UK, 1992. http://dx.doi.org/10.1007/978-1-349-22495-1_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ivashkov, Yulia, Alexander A. Vitin, and G. Alec Rooke. "General Anesthesia: Intravenous Induction Agents, Inhalational Agents, and Neuromuscular Blockers." In Manual of Geriatric Anesthesia. Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-3888-5_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Caldwell, James E. "A History of Neuromuscular Block and Its Antagonism." In The Wondrous Story of Anesthesia. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-8441-7_50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lee, Chingmuh, Xiaoyan Zhang, and Wing-Fai Kwan. "Neuromuscular Refractoriness, Prejunctional Block and MgSO4 in the Pig." In Muscle Relaxants. Springer Japan, 1995. http://dx.doi.org/10.1007/978-4-431-66896-1_73.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lin, Su-Man, Shen-Kuo Tsai, and Tak-Yu Lee. "Do Antiarrhythmic Dose of Magnesium Have Prejunctional Neuromuscular Block in Human Being." In Muscle Relaxants. Springer Japan, 1995. http://dx.doi.org/10.1007/978-4-431-66896-1_97.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kodaka, Mitsuharu, Hideki Miyao, Jun Kawasaki, et al. "A Method for Studying Interaction Between Non-Deporalizing Neuromuscular Blockers and Other Drugs in Vivo." In Muscle Relaxants. Springer Japan, 1995. http://dx.doi.org/10.1007/978-4-431-66896-1_65.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Neuromuscular blocker"

1

Ho, A. T. N., and S. Patolia. "Neuromuscular Blocker in Acute Respiratory Distress Syndrome. A Meta-Analysis." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4601.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Steingrub, Jay, Brian H. Nathanson, Tara Lagu, Michael B. Rothberg, and Peter K. Lindenauer. "Effect Of Neuromuscular Blockers On Mortality In Patients With Severe Sepsis." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2494.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Agarwal, Santosh J., Mary G. Erslon, and Scott D. Kelley. "Impact Of Neuromuscular Blockers On Time On Mechanical Ventilation And Surgical Patient Outcomes." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a1634.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Yi-Ting. "Post-intubation cardiac arrest events in patients of acute respiratory failure: compare neuromuscular blockers (NMBs) for rapid sequence intubation (RSI)." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa3565.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Neuromuscular blocker"

1

Stanek, Maria. Choice of Intravenous Agents and Intubation Neuromuscular Blockers by Anesthesia Providers. Defense Technical Information Center, 1996. http://dx.doi.org/10.21236/ad1011552.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Johnson, Corey, Colton James, Sarah Traughber, and Charles Walker. Postoperative Nausea and Vomiting Implications in Neostigmine versus Sugammadex. University of Tennessee Health Science Center, 2021. http://dx.doi.org/10.21007/con.dnp.2021.0005.

Full text
Abstract:
Purpose/Background: Postoperative nausea and vomiting (PONV) is a frequent complaint in the postoperative period, which can delay discharge, result in readmission, and increase cost for patients and facilities. Inducing paralysis is common in anesthesia, as is utilizing the drugs neostigmine and sugammadex as reversal agents for non-depolarizing neuromuscular blockers. Many studies are available that compare these two drugs to determine if neostigmine increases the risk of PONV over sugammadex. Sugammadex has a more favorable pharmacologic profile and may improve patient outcomes by reducing P
APA, Harvard, Vancouver, ISO, and other styles
3

MALDONADO, KARELYS, JUAN ESPINOZA, DANIELA ASTUDILLO, and WILSON BRAVO. Fatigue and fracture resistance and survival of occlusal veneers of composite resin and ceramics blocks in posterior teeth with occlusal wear: A protocol for a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0036.

Full text
Abstract:
Review question / Objective: The aim of this systematic review is to synthesize the scientific evidence that evaluates fatigue and fracture resistance, survival, and stress distribution, of composite resin CAD/CAM and ceramic CAD/CAM occlusal veneers in posterior teeth with severe occlusal wear. Condition being studied: Currently there is an increase in cases of dental wear, due to several factors such as: excessive consumption of carbonated drinks, a diet high in acids, gastric diseases, anorexia, bulimia, dental grinding, use of highly abrasive toothpastes, or a combination of these(9) (10)
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Neuromuscular blocker' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography